IL23A and myeloid sarcoma: A deficiency of the Th17-related cytokine IL23, but not of the Th1-related cytokine IL12, induces resistance to EAE, implying that Th17 cells are the chief contributors to EAE/MS [28], whereas Th1 cells can consistently transfer EAE disease [16, 17].